Introduction
In the Western Highlands of Scotland, cattle are affected by florid persistent viral papillomatosis of the upper alimentary canal (1) and are at much higher risk for the development of squamous cell carcinomas than lowland animals. The geographical distribution of cancer overlaps with that of the bracken fern, and strong circumstantial evidence has pointed to the fern as the environmental cofactor, suggesting that the progression of papillomas to carcinomas is due to the interplay between the viral agent and chemicals present in the plant (2) .
The virus has been identified as bovine papillomavirus type 4 (BPV-4*), an epitheliotropic papillomavirus that infects solely the mucous epithelium of the alimentary canal (3) . In healthy immunocompetent animals, BPV-4 infection is selflimiting; the papillomas are subjected to immunological control and regress ~1 year after infection (4) . However, in brackengrazing animals the papillomatosis may be florid and persistent. These long-lasting papillomas can become the focus for neoplastic conversion to squamous cell cancer (2) . Animals with carcinomas of the upper alimentary canal often present with adenomas and adenocarcinomas of the lower intestine and with carcinomas and hemangiosarcomas of the urinary bladder (2); they are also immunosuppressed. Epidemiologically these diseases have been defined as diverse manifestations of the combined effects of infection by papillomavirus and of grazing on bracken fern. Indeed the fern has been shown to contain, in addition to mutagens (5), also powerful immunosuppressants (6) .
Synergism with cofactors is a characteristic of papillomavirus (7) and the BPV-4 system provides an opportunity for studying the individual roles and the concerted action of the viral and chemical agents involved in malignant transformation. Thus, in August 1979 we started an experiment designed to reproduce in controlled conditions the co-carcinogenic action of virus and bracken, and to distinguish between the effects of the bracken mutagens and immunosuppressants (8) . The reactivation of latent virus and the induction of urinary bladder cancers in immunosuppressed animals have been reported (9, 10) . Here we present the experimental reproduction of the papilloma-carcinoma syndrome in animals infected with BPV-4 and given a diet of bracken.
Materials and methods

Experimental plan
This has been described in detail in ref. (10) . Briefly, 36 young animals, -3-5 months old and born of papillomatosis-free mothers, were divided into eight groups. Group 1 (animals 1-6) was made up of six calves inoculated with BPV-4; group 2 (animals 7-12) was made up of six calves inoculated with BPV-4 and treated with the immunosuppressant azathioprine; group 3 (animals 13-16) was made up of four calves treated only with azathioprine; group 4 (animals [17] [18] [19] [20] was made up of four control calves; group 5 (animals 21 -26) was made up of six calves fed a diet of bracken fern; group 6 (animals 27-32) was made up of six calves inoculated with BPV-4 and fed with bracken; group 7 (animals 33 and 34) was made up of two calves administered quercetin, a mutagenic flavonoid present in bracken; group 8 (animals 35 and 36) was made up of two calves inoculated with BPV-4 and administered quercetin.
The animals were cared for in complete accordance with the directives of the Home Office of Great Britain.
BPV-4 purification, typing and infection
These techniques were as previously described (3, 11, 12) . Briefly BPV-4 was purified from macerated tumour tissue on CsCl density gradients and typed by restriction enzyme mapping, Southern blotting and immunohistochemistry. Infection was by intramucosal injection into the palate under Rompun light general anaesthesia.
Haematological analysis
Animals were bled from the jugular vein every 5 days for the first 35 weeks and each month thereafter. Quantitative assays were by Coulter Counter and differential leucocyte percentages were based on 400 cells. Lymphocytes were separated from blood and other blood cells by Ficol Hypaque (Pharmacia).
Treatment with azathioprine
The azathioprine solution was prepared by dissolving 2 g azathioprine powder (Calmic Medical Division, The Wellcome Foundation Ltd) in 90 ml sterile saline solution by dropwise addition of 7.24 ml 1 N NaOH. It was administered daily to the designated calves by s.c. injection at a dose of 2 mg/kg body wt.
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pens housing the designated animals every day from the beginning of June to the end of September, with an interval of 3 weeks after the first 6 weeks. During the winter months the animals were fed on hay. The bracken feeding cycle was repeated every year to the end of the experiment. The quantities eaten by each calf are unknown because ad libitum feeding was used.
Treatment with quercetin
Quercetin (5,7,3',4'-tetrahydroxyflavone, Sigma) was dissolved in DMSO and ethanol and administered to the designated calves at a dose of 1 g/calf/day orally for 5 months. Thereafter the dose was increased to 20 g/calf/day. Treatment was suspended for a month every 4 months.
Further details about the several experimental regimes can be found in ref. (10) .
Collection of alimentary canal tumours
Papillomas and cancers were obtained at autopsy; one half of each specimen was used for histopathology and the other half was frozen in liquid nitrogen as soon as possible after excision and then stored at -20°C until needed for DNA analysis.
BPV sequences in tumour tissue
The isolation and purification of tissue DNA, restriction enzyme analysis and Southern blot hybridization were as described in ref. (13). The hybridization probes were DNA from recombinant BPV-4 or BPV-2 (14) radioactively labelled either by nick-translation or by random priming.
Results
Immunosuppression by bracken eating and by azathioprine treatment
The effect of bracken eating and of azathioprine treatment on the immune system has been described in detail before (10) . Briefly, animals eating bracken fern (groups 5 and 6) underwent a rapid dramatic drop in polymorphonuclear leukocytes; if unchecked this leads to death from septicemia. Bracken feeding was therefore periodically stopped and during these times the polymorphonuclear cell count returned to near normal levels. The count of circulating lymphocytes was, however, chronically depressed and remained so throughout the experiment.
Administration of azathioprine (groups 2 and 3) produced a marked drop in peripheral blood leukocytes with severe immunosuppression and hematuria. Given the degree of immunosuppression these animals were killed after 2 years of treatment.
In contrast to the dramatic effects caused by bracken feeding and by treatment with azathioprine, administration of quercetin (groups 7 and 8) had no effect on the immune status of the animals.
Papillomas of the alimentary canal
All animals infected with BPV-4 developed typical epithelial papillomas ~6 weeks later. In groups 1 and 8 the papillomas were confined to the injection sites, similar in this to naturally occurring papillomas in immunocompetent animals ( Figure  1A ), and were rejected after 1 year. In contrast, in the immunosuppressed animals (group 2, azathioprine, and group 6, bracken) the papillomas spread throughout the oro-and nasopharynx, often coalescing in numerous large clumps ( Figure 1C ), similar to the massive papillomatosis encountered in field cases ( Figure IB) , and did not undergo regression; the azathioprine-treated animals still had papillomas at the time of their death, and the bracken fed animals mantained their tumours for the rest of their life: animal 29 died in October 1992 and, 13 years after infection, still had papillomas which had spread from the mouth to the lower oesophagus and the rumen. Therefore immunosuppression induced the spread of papillomas and allowed their persistence well beyond their average lifespan in immunocompetent animals. Spread and persistence of papillomas did not take place in the animals detected in their alimentary tract other than papillomas in group 2 animals. All the bracken fed animals (groups 5 and 6) developed urinary bladder malignancies (10), but only two animals from group 6 (bracken plus virus) developed cancers of the upper alimentary canal and the lower intestine. Animal 30 was killed in September 1985; this animal presented with typical papillomas in the palate, tongue and oesophagus ( Figure  2A ), two foci of carcinoma in the oesophagus, infiltrating the subjacent tissue ( Figure 2B ) and multiple polyps, adenomas and adenocarcinomas in the duodenum, jejunum and colon ( Figure 2C and D) . Animal 31 was killed in November 1989; this animal had papillomas and carcinoma of the oesophagus, similar to those described for animal 30, and adenocarcinoma of the jejunum.
No malignancies of the alimentary tract were detected in animals of the other groups.
BPV-4 DNA in alimentary papillomas and carcinomas
Papillomas excised 3 months after infection contained multiple copies of episomal BPV-4 DNA ( Figure 3A) . In contrast, and as previously reported for naturally occurring cases (4,13), the long-lived papillomas, the oesophageal carcinomas and the tumours of the lower intestine of animals 30 and 31 were devoid of viral DNA ( Figure 3B and data not shown) . The hybridization conditions were such that one copy of viral DNA per cell was easily detected in control samples ( Figure 3B ). Despite the presence of BPV-2 DNA in the urinary bladder cancers of these animals, no BPV-2 DNA was present in the alimentary cancers (data not shown).
Discussion
We have experimentally reproduced the alimentary canal papilloma-carcinoma syndrome, as encountered in the field, by infecting cattle with papillomavirus and feeding them on a diet of bracken, thereby confirming the viral-environmental nature of the disease. The importance of bracken-induced immunosuppression in reactivation of latent virus and in carcinogenesis of the urinary bladder in conjunction with BPV-2 has already been documented and discussed (9,10). Here we show that the effects of combined exposure to the immunosuppressants and co-carcinogens of the fern and to BPV-4 infection result in the induction of widespread alimentary papillomatosis and of cancers of both the upper and lower alimentary tract.
We have dissociated the effects of immunosuppression from the possible effects of exposure to co-carcinogens. Immunosuppressed animals, independently from the route of immunosuppression, are not capable of containing BPV-4 infection and papillomas thus spread and persist. However, immunosuppression appears to be necessary but not sufficient for neoplastic progression, and additional carcinogenic compounds present in the fern seem to be required. This conclusion stems from the observation that azathioprine-treated animals did not develop alimentary tract malignancies, while brackenfed animals did. A similar situation was observed in the urinary bladder: frank cancers developed only in bracken-fed animals in contrast to premalignant lesions seen in azathioprine-treated animals (10) . It has to be pointed out, however, that the azathioprine-treated animals had to be killed earlier than the bracken-fed ones, and it is a formal possibility that they might have developed cancer had they lived longer.
One of the most potent mutagens present in bracken fern is the flavonoid quercetin (5, (15) (16) (17) (18) (19) . We have recently reported that quercetin rapidly synergizes with BPV-4 in the induction of fully oncogenic transformation of primary bovine fetal cells in vitro (20) . However, quercetin-treated animals were no different from control animals, and did not develop any tumour other than BPV-4 papillomas. It is possible that the absence of discernible effects of quercetin treatment was due to the immunological competence of these animals, and that any transformed cell was eliminated by immunosurveillance mechanisms. This would confirm that both immunosuppression and exposure to co-carcinogens are necessary for neoplastic conversion.
In contrast to the presence of BPV-2 DNA in the premalignant and malignant lesions of the urinary bladder in the azathioprine-treated and bracken-fed animals respectively (10), BPV-4 DNA was present only in the early papillomas of the alimentary tract but not in advanced papillomas, oesophageal carcinomas or adenomas and adenocarcinomas of the lower intestine. This is the situation encountered in the corresponding naturally occurring tumours where the absence of viral genetic information is well documented (13), thus showing concordance between field cases and experimentally induced tumours also in this respect. Several possibilities can be invoked to explain this apparent paradox. The most minimalistic explanation is that there is no relation between viral papillomas and carcinomas: these would arise de novo or from papillomas with no viral etiology, and would be due solely to the carcinogenic action of bracken. Although formally possible, we do not favour this hypothesis. In addition to the arguments that have been presented before (13), the absence of alimentary papillomas and cancers in bracken-fed animals not infected with BPV-4 makes this alternative implausible. The presence of a different BPV type with a causative role in alimentary tract carcinogenesis is unlikely as well characterized BPV-4 was used in the present experiments and different molecular probes representing the spectrum of BPV types have repeatedly failed in detecting viral sequences in cancers. We have recently reported the spontaneous malignant transformation, with metastasis to the spleen, of a bovine papilloma induced by BPV-4 (21) in the nude mouse xenograft system (22). The derivation of the cancer from the viral papilloma could not be disputed, but nevertheless no viral DNA could be detected by the highly sensitive polymerase chain reaction in the malignant tissue. For all these reasons and because of results obtained in vitro (23) , the most coherent explanation for the absence of viral genetic information in alimentary cancers is that the role of BPV-4 in carcinogenesis is confined to the early transformation stages. Cell proliferation induced by BPV-4 would provide a largely expanded target for the bracken co-carcinogens. The further expansion of initiated/transformed cells and protracted presence of papillomas, both allowed by poor immunosurveillance, would increase the probability of additional events, such as activation of the ras gene (24) and amplification of the receptors for epidermal growth factor (25) with the eventual emergence of a fully malignant clone. Viral functions would no longer be needed and there would be no selective pressure for retaining the viral DNA.
